Jul
2026
QSNCC, Bangkok, Thailand
Visit us
stand G50
Zone

Hainan Zhonghe Pharmaceutical Co., Ltd

About Us

Hainan Zhonghe Pharmaceutical Co., Ltd, established in 1995, is the first high-tech enterprise specialized in development, production and marketing of peptide drugs in China. Our plants are equipped with the most advanced peptide synthesis and purification facilities. Our therapeutic areas are  oncology & immune system, gastroenterology, gynecology, cardiovascular etc.


  • Country/Region:
    China
  • On CPHI since:
    2015
  • Certificates:
    1
  • Employees:
    250 - 499
Company types
Generics/Biosimilars Manufacturer
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
Contact info
Event information
CPHI South East Asia 2026
  • 08 Jul 2026 - 10 Jul 2026
  • QSNCC, Bangkok, Thailand
  • Visit us at stand G50

Products Featured at CPHI South East Asia 2026

  • Entecavir Dispersible Tablets and Capsules

    Product Entecavir Dispersible Tablets and Capsules

    Strength: 0.5 mg Entecavir is used to treat chronic (long-term) hepatitis B infection (swelling of the liver caused by a virus) in adults and children 2 years of age and older who have liver damage.
  • Eptifibatide Injection

    Product Eptifibatide Injection

    Strength: 20 mg/10 ml It is used for the prevention of early myocardial infarction in adults presenting with unstable angina or non-Q-wave myocardial infarction, and for platelet aggregation
  • Ganirelix Acetate Injection

    Product Ganirelix Acetate Injection

    Strength: 0.25 mg/0.5 ml. Ganirelix is a GnRH antagonist used in assisted reproduction in women undergoing controlled ovarian hyperstimulation to control ovulation by inhibiting the premature LH surges.
  • Atosiban Acetate Injection

    Product Atosiban Acetate Injection

    Atosiban is an inhibitor of the hormones oxytocin and vasopressin. It is used as an intravenous medication as a labour repressant to halt premature labor. Atosiban Acetate Injection is indicated to delay imm...
  • Bivalirudin for Injection

    Product Bivalirudin for Injection

    It is s indicated for use as an anticoagulant in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty (PTCA).

Hainan Zhonghe Pharmaceutical Co., Ltd. Resources (1)